Risk of Self-Harm Elevated in Patients With Ankylosing Spondylitis
Jun 20, 2018
This study suggests a link between inflammatory arthritis and the development of serious mental health consequences.
Rheumatology Network Staff
NSAIDs a Key Culprit in Cardiovascular Risk in Osteoarthritis
Jun 18, 2018
A substantial proportion of the increased cardiovascular risk in patients with OA can be attributed to these commonly used drugs.
Best to Treat Rheumatoid Arthritis Early and Aggressively for Optimal Outcomes
Jun 14, 2018
Early, intensive treatment of RA has long-term benefits, including a reduction in mortality, report Dutch researchers at EULAR 2018.
Biomarkers Identify Patients at Risk for Hip Replacement Failure
Jun 12, 2018
Urinary markers may predict the development of osteolysis following total hip replacement.
FDA Gives Nod to Baricitinib 2-mg Tablets for Moderate to Severe RA in Adults
Jun 4, 2018
The approval is based on phase 3 clinical data that demonstrated efficacy for difficult to treat rheumatoid arthritis.
Lupus: 5 Questions on Diagnosis
Jun 1, 2018
Brush up on the diagnosis of systemic lupus erythematosus with 5 questions based on the recent British Society for Rheumatology guidelines.
Certolizumab Gets FDA Nod for Moderate to Severe Plaque Psoriasis in Adults
May 29, 2018
The approval makes Cimzia the first Fc-free, PEGylated anti-TNF treatment option for this indication.
FDA Gives Nod to Denosumab for Glucocorticoid-Induced Osteoporosis
May 22, 2018
Fifth indication for Prolia for men and women at high risk for fracture who are receiving systemic glucocorticoids.
TNF Inhibitor Use in Pregnancy Does Not Raise Serious Infection Risk in Children
May 21, 2018
Reassuring news for women with rheumatoid arthritis who need treatment with a TNF inhibitor during pregnancy.
Subcutaneous Tocilizumab Gets FDA Nod for Rare Form of Juvenile Arthritis
May 17, 2018
Actemra can be given alone or in combination with methotrexate in patients with polyarticular juvenile idiopathic arthritis.
